NTI

1.75%

5.8¢ neurotech international limited

anticipated results, page-19

First 19 Last

Share
Profile

Follow
GCInvestor

5,448 Posts.

1285

08/01/18

14:31

Post #: 30128798
Share

Originally posted by TerribleTadpole ↑

Correct. There's a lengthy waiting list of articles waiting for publication in the most respected journals: waiting for peers to be available to conduct the review, then waiting while the peers conduct the review, then waiting in the queue for publication. Really big news can often be summarised earlier in "letters".

In my view, this constraint — "The final results of the study will not be available to Neurotech or the public until the investigation has been published" (italics and underscore are mine) — raises questions over the timing of the FDA application:

1) Can the FDA application be submitted without the trial results? Surely not... otherwise why are we conducting the trial?

2) Can the trial results be submitted directly to the FDA independently by the operators without disclosure to Neurotech? Again, surely not because until the work is reviewed it has no credibility.

I suspect that this is why the market has offloaded NTI... investors have realised they have a wait of up to 6 months before further action is likely. They'll be looking for opportunities in the interim.

Expand

from the last presentation

 Q1 2018: Results of US clinical trial
 Q1 2018: US FDA submission
 Q2 2018: Publication of US trial results in peerreviewed publications
 2018: US FDA determination

seems odd .. will email for some clarification

NTI Price at posting: 22.0¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

First 19 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 5.8¢		Change 0.001(1.75%)		Mkt cap ! $60.00M

Open	High	Low	Value	Volume
5.9¢	5.9¢	5.8¢	$61.32K	1.042M

Buyers (Bids)

No.	Vol.	Price($)
2	188378	5.8¢

Sellers (Offers)

Price($)	Vol.	No.
6.0¢	490015	8

View Market Depth

No.	Vol.	Price($)
1	88378	0.058
1	100000	0.057
4	267571	0.056
3	1382636	0.055
2	571649	0.054

Price($)	Vol.	No.
0.060	490015	8
0.061	471997	2
0.064	200000	1
0.065	56436	2
0.066	166666	1

Last trade - 15.52pm 15/11/2024 (20 minute delay)

NTI (ASX) Chart

anticipated results, page-19

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

anticipated results, page-19

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News